INDP
Indaptus Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.22
+5.17%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-135.6%
Return on equity
-128.7%
Return on assets
-129.9%
Return on invested capital
0.00x
Asset turnover
-$15.2M
Cash from operations
$0.09
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026